Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Analgesic Compound Efficacy (PACE) Study

NCT02403687 is registered in ClinicalTrials.gov with Express Specialty Pharmacy as lead sponsor.

NCT NCT02403687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02403687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Analgesic Compound Efficacy (PACE) Study
Lead sponsor
Express Specialty Pharmacy
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
February 28, 2017
Enrollment
300 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, gout, headache, migraine, muscle spasms, radiculopathy, synovitis, tendonitis